Fidelix Co. Ltd (032580.KQ) stock: key figures, P/E, revenue and dividend
Information Technology · Semiconductors · South Korea · ISIN KR7032580003
Fidelix Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 44.81 bn KRW | 53.62 bn KRW |
| Gross profit | 6.47 bn KRW | 7.79 bn KRW |
| Operating income | -4.53 bn KRW | -2.07 bn KRW |
| EBIT | -1.99 bn KRW | -2.77 bn KRW |
| Net income | -2.21 bn KRW | -2.96 bn KRW |
| Diluted EPS – continuing operations | -66.63 KRW | -89.49 KRW |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Fidelix Co. Ltd
Fidelix Co., Ltd. focuses on developing memories for wireless devices. It provides low power SDRAM, low power DDR SDRAM, low power DDR2 SDRAM, DDR3 SDRAM, and Pseudo SRAM products; NAND FLASH, SPI NAND FLASH, and SPI NOR FLASH series products; and NAND based and NOR based MCP products. Fidelix Co., Ltd. was incorporated in 1990 and is headquartered in Seongnam-si, South Korea.
More stocks
- Super Turtle PCL (TURTLE.BK)
- Deezer S.A. (DEEZR.PA)
- AirJoule Technologies Corp. (AIRJ)
- Fiera Capital Corporation (FSZ.TO)
- Niagen Bioscience, Inc. (NAGE)
- NRC Group ASA (NRC.OL)
- United Pharm (033270.KS)
- VINCE HOLDING CORP. (VNCE)
- Donga Geologic (028100.KS)
- OptimizeRx Corp (OPRX)
- AN2 Therapeutics, Inc. (ANTX)
- Pappajack Bhd (0242.KL)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.